Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases

Detalhes bibliográficos
Autor(a) principal: Chaves, Beatriz
Data de Publicação: 2018
Outros Autores: Aquino, Carolina Lessa, Silva, João Hermínio Martins da, Medeiros, Marco Alberto, Savino, Wilson, Riederer, Ingo, Almeida, Vinícius Cotta de
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/27260
Resumo: Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.
id CRUZ_d72f67ecb64be4982932d34c97b997f8
oai_identifier_str oai:www.arca.fiocruz.br:icict/27260
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Chaves, BeatrizAquino, Carolina LessaSilva, João Hermínio Martins daMedeiros, Marco AlbertoSavino, WilsonRiederer, IngoAlmeida, Vinícius Cotta de2018-07-03T19:34:39Z2018-07-03T19:34:39Z2018CHAVES, B. et al. Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases. In: SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 6., 2018, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2018. p. 60-61.https://www.arca.fiocruz.br/handle/icict/2726010.35259/isi.sact.2018_27260engFiocruz/Instituto de Tecnologia em ImunobiológicosscFvVLA-4DesenvolvimentoscFvVLA-4DevelopmentAnticorpos de Cadeia ÚnicaIntegrina alfa4beta1Crescimento e DesenvolvimentoProduction of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseasesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Fiocruz Ceará. Fortaleza, CE, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/27260/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51TEXTBIO.08.pdf.txtBIO.08.pdf.txtExtracted texttext/plain1https://www.arca.fiocruz.br/bitstream/icict/27260/3/BIO.08.pdf.txt68b329da9893e34099c7d8ad5cb9c940MD53ORIGINALBIO.08.pdfBIO.08.pdfapplication/pdf174108https://www.arca.fiocruz.br/bitstream/icict/27260/4/BIO.08.pdf308020c32ce9946eafa5a3e2da318ee1MD54icict/272602023-04-26 17:06:26.571oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T20:06:26Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
title Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
spellingShingle Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
Chaves, Beatriz
scFv
VLA-4
Desenvolvimento
scFv
VLA-4
Development
Anticorpos de Cadeia Única
Integrina alfa4beta1
Crescimento e Desenvolvimento
title_short Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
title_full Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
title_fullStr Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
title_full_unstemmed Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
title_sort Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases
author Chaves, Beatriz
author_facet Chaves, Beatriz
Aquino, Carolina Lessa
Silva, João Hermínio Martins da
Medeiros, Marco Alberto
Savino, Wilson
Riederer, Ingo
Almeida, Vinícius Cotta de
author_role author
author2 Aquino, Carolina Lessa
Silva, João Hermínio Martins da
Medeiros, Marco Alberto
Savino, Wilson
Riederer, Ingo
Almeida, Vinícius Cotta de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Chaves, Beatriz
Aquino, Carolina Lessa
Silva, João Hermínio Martins da
Medeiros, Marco Alberto
Savino, Wilson
Riederer, Ingo
Almeida, Vinícius Cotta de
dc.subject.other.pt_BR.fl_str_mv scFv
VLA-4
Desenvolvimento
topic scFv
VLA-4
Desenvolvimento
scFv
VLA-4
Development
Anticorpos de Cadeia Única
Integrina alfa4beta1
Crescimento e Desenvolvimento
dc.subject.en.pt_BR.fl_str_mv scFv
VLA-4
Development
dc.subject.decs.pt_BR.fl_str_mv Anticorpos de Cadeia Única
Integrina alfa4beta1
Crescimento e Desenvolvimento
description Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.
publishDate 2018
dc.date.accessioned.fl_str_mv 2018-07-03T19:34:39Z
dc.date.available.fl_str_mv 2018-07-03T19:34:39Z
dc.date.issued.fl_str_mv 2018
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv CHAVES, B. et al. Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases. In: SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 6., 2018, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2018. p. 60-61.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/27260
dc.identifier.doi.none.fl_str_mv 10.35259/isi.sact.2018_27260
identifier_str_mv CHAVES, B. et al. Production of a scFv antagonistic to VLA-4 protein as a potential biopharmaceutical for chronic inflammatory diseases. In: SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 6., 2018, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2018. p. 60-61.
10.35259/isi.sact.2018_27260
url https://www.arca.fiocruz.br/handle/icict/27260
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/27260/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/27260/3/BIO.08.pdf.txt
https://www.arca.fiocruz.br/bitstream/icict/27260/4/BIO.08.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
68b329da9893e34099c7d8ad5cb9c940
308020c32ce9946eafa5a3e2da318ee1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009293978370048

Registros relacionados